Status:
RECRUITING
Effectiveness of Trauma Therapy Using Prolonged Exposure for Patients With PTSD and a Comorbid Psychotic Disorder
Lead Sponsor:
Medicalschool Hamburg
Collaborating Sponsors:
Psychiatrische Klinik Lüneburg
Regioklinikum Elmshorn
Conditions:
Post Traumatic Stress Disorder
PTSD
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Psychosis patients with comorbid PTSD will be treated with trauma therapy.
Detailed Description
This is a monocentric, controlled, prospective, randomised trial. (RCT). The study population is outpatients with psychotic illness and comorbid post-traumatic stress disorder who have applied for out...
Eligibility Criteria
Inclusion
- Presence of a psychotic disorder (F20) or affective disorder with psychotic symptoms(F30) according to DSM-5.
- comorbid post-traumatic stress disorder (PTSD) according to DSM-5 (CAPS-5 score ≥ 23)
- At least 18 years old
- Good knowledge of the German language
- Willingness to participate in randomisation and trauma-focused therapy
Exclusion
- Changes in neuroleptic or antidepressant therapy within the last 4 weeks (exclusion of drug effects).
- Any substance dependence with continued use other than nicotine and/or caffeine dependence.
- IQ of 70 or less
- Acute suicidality
- Pregnant women
Key Trial Info
Start Date :
May 15 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 17 2028
Estimated Enrollment :
56 Patients enrolled
Trial Details
Trial ID
NCT06048172
Start Date
May 15 2023
End Date
May 17 2028
Last Update
September 21 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medicalschool Hamburg
Hamburg, Germany, 20457